Biotinylated Human BTLA (31-150) Protein, His,Avitag(TM) (MALS verified)

Produktübersicht

• Artikelname: Biotinylated Human BTLA (31-150) Protein, His,Avitag(TM) (MALS verified)
• Artikelnummer: ABS-BTA-H82E4-25UG
• Hersteller Artikelnummer: BTA-H82E4-25ug
• Alternativnummer: ABS-BTA-H82E4-25UG
• Hersteller: AcroBiosystems
• Wirt: Human
• Kategorie: Proteine/Peptide
• Spezies Reaktivität: Human
• Konjugation: Biotin

Produktbeschreibung

B and Tlymphocyte attenuator (BTLA) is also known as B and Tlymphocyteassociated protein, CD antigen CD272. BTLA contains one Iglike Vtype (immunoglobulinlike) domain. As a lymphocyte inhibitory receptor, BTLA / CD272 inhibits lymphocytes during immune response. BTLA / CD272 can interact with tyrosine phosphatases PTPN6/SHP1 and PTPN11/SHP2, and interact with TNFRSF14/HVEM. - Proteine/Peptide

Produkteigenschaften

• Molekulargewicht: 17.4 kDa
• Tag: C-10*His & C-Avi
• NCBI: 44003
• Puffer: PBS, pH7.4
• Reinheit: 90%
• Formulierung: Powder
• Target-Kategorie: BTLA

Bilder

Immobilized Biotinylated Human BTLA (31-150), His,Avitag (Cat. No. BTA-H82E4) at 1 µg/mL (100 µL/well) on streptavidin (Cat. No. STN-N5116) precoated (0.5 µg/well) plate can bind Human HVEM, Mouse IgG2a Fc Tag, low endotoxin with a linear range of 2-78 ng/mL (QC tested).

BTA-H82E4-25ug

Biotinylated Human BTLA (31-150), His,Avitag on SDS-PAGE under reducing (R) condition. The gel was stained overnight with Coomassie Blue. The purity of the protein is greater than 90%.